Combination of Omega-3 Fatty Acids and Valproic Acid in Treatment of Borderline Personality Disorder: A Follow-Up Study.
Paola BozzatelloPaola RoccaSilvio BellinoPublished in: Clinical drug investigation (2018)
The trial was registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) and allocated the code: ACTRN12612001150831.